Look behind the lecture: population-level precision medicine – an interview with Elina Hypponen

In this feature, following her moderation of a plenary session at the International Society for Pharmacoeconomics and Outcomes Research’s 2020 Asia Pacific meeting (Virtual ISPOR Asia Pacific 2020; 14–16 September), Elina Hypponen (Australian Centre for Precision Health, Adelaide, South Australia) discusses the potential benefits of precision medicine approaches at the population level, as well as some of the tough questions we must tackle on our path to realizing these. Please could you introduce yourself and your organization(s)? I am the Director of the Australian Centre for Precision Health and a Professor in Nutritional and Genetic Epidemiology at the University of...